Literature DB >> 27533308

High Normal Uric Acid Levels Are Associated with an Increased Risk of Diabetes in Lean, Normoglycemic Healthy Women.

Michal Shani1, Shlomo Vinker1, Dganit Dinour1, Merav Leiba1, Gilad Twig1, Eliezer J Holtzman1, Adi Leiba1.   

Abstract

CONTEXT: The risk associated with serum uric acid (SUA) levels within the normal range is unknown, especially among lean and apparently healthy adults.
OBJECTIVE: Evaluating whether high-normal SUA levels, 6.8 mg/dL and below, are associated with an increased diabetes risk, compared with low-normal SUA. DESIGN AND
SETTING: This was a cohort study with 10 years of followup involving all clinics of the largest nationally distributed Health Maintenance Organization in Israel. PARTICIPANTS: Participants included 469,947 examinees, 40-70 years old at baseline, who had their SUA measured during 2002. We excluded examinees who had hyperuricemia (SUA > 6.8 mg/dL), impaired fasting glucose, overweight or obesity and chronic cardiovascular or renal disorders. The final cohort was composed of 30 302 participants.
INTERVENTIONS: Participants were followed up to a new diagnosis of diabetes during the study period. MAIN OUTCOME MEASURES: Odds ratio of developing diabetes among participants with high-normal baseline SUA were compared with low-normal (2 ≤ uric acid < 3 and 3 ≤ uric acid < 4 in women and men, respectively).
RESULTS: In a logistic regression model adjusted for age, body mass index, socioeconomic status, smoking, baseline estimated glomerular filtration rate, and baseline glucose, SUA levels of 4-5 mg/dL for women were associated with 61% increased risk for incident diabetes (95% confidence interval, 1.1-2.3). At the highest normal levels for women (SUA, 5-6 mg/dL) the odds ratio was 2.7 (1.8-4.0), whereas men had comparable diabetes risk at values of 6-6.8 mg/dL (hazard ratio, 1.35; 95% confidence interval, 0.9-2.1).
CONCLUSIONS: SUA levels within the normal range are associated with an increased risk for new-onset diabetes among healthy lean women when compared with those with low-normal values.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27533308     DOI: 10.1210/jc.2016-2107

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?

Authors:  Ambreen Gul; Philip Zager
Journal:  Curr Diab Rep       Date:  2018-03-01       Impact factor: 4.810

2.  Changes Over Time in Uric Acid in Relation to Changes in Insulin Sensitivity, Beta-Cell Function, and Glycemia.

Authors:  Alessandro Volpe; Chang Ye; Anthony J Hanley; Philip W Connelly; Bernard Zinman; Ravi Retnakaran
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

3.  Sex-Specific Associations of Circulating Uric Acid with Risk of Diabetes Incidence: A Population-Based Cohort Study from Sweden.

Authors:  Ning Chen; Iram Faqir Muhammad; Zhibin Li; Peter M Nilsson; Yan Borné
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-12       Impact factor: 3.168

Review 4.  Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.

Authors:  Usama A A Sharaf El Din; Mona M Salem; Dina O Abdulazim
Journal:  J Adv Res       Date:  2016-12-03       Impact factor: 10.479

5.  Lower serum uric acid level strongly predict short-term poor functional outcome in acute stroke with normoglycaemia: a cohort study in China.

Authors:  Shuolin Wu; Yuesong Pan; Ning Zhang; Wang Yong Jun; Chunxue Wang
Journal:  BMC Neurol       Date:  2017-02-01       Impact factor: 2.474

6.  Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout.

Authors:  Yannan Zhang; Huanzhen Zhang; Dong Chang; Fuchuan Guo; Hongzhi Pan; Yuexin Yang
Journal:  Arthritis Res Ther       Date:  2018-06-05       Impact factor: 5.156

7.  Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study.

Authors:  Edoardo Casiglia; Valérie Tikhonoff; Agostino Virdis; Stefano Masi; Carlo M Barbagallo; Michele Bombelli; Bernardino Bruno; Arrigo F G Cicero; Massimo Cirillo; Pietro Cirillo; Giovambattista Desideri; Lanfranco D'Elia; Claudio Ferri; Ferruccio Galletti; Loreto Gesualdo; Cristina Giannattasio; Guido Iaccarino; Luciano Lippa; Francesca Mallamaci; Alessandro Maloberti; Alberto Mazza; Maria Lorenza Muiesan; Pietro Nazzaro; Paolo Palatini; Gianfranco Parati; Roberto Pontremoli; Fosca Quarti-Trevano; Marcello Rattazzi; Giulia Rivasi; Massimo Salvetti; Giuliano Tocci; Andrea Ungar; Paolo Verdecchia; Francesca Viazzi; Massimo Volpe; Guido Grassi; Claudio Borghi
Journal:  J Hypertens       Date:  2020-03       Impact factor: 4.776

Review 8.  Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications.

Authors:  Qing Xiong; Jie Liu; Yancheng Xu
Journal:  Int J Endocrinol       Date:  2019-10-13       Impact factor: 3.257

9.  NMR-Based Metabonomic Study Reveals Intervention Effects of Polydatin on Potassium Oxonate-Induced Hyperuricemia in Rats.

Authors:  Bin Han; Mengjuan Gong; Zhong Li; Yuqin Qiu; Zhongjie Zou
Journal:  Oxid Med Cell Longev       Date:  2020-07-05       Impact factor: 6.543

Review 10.  Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment.

Authors:  Julia Hernandez-Baixauli; Sergio Quesada-Vázquez; Roger Mariné-Casadó; Katherine Gil Cardoso; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Laura Baselga-Escudero
Journal:  Nutrients       Date:  2020-03-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.